Opill Norgestrel Tablets: payments to doctors
Payments that named Opill Norgestrel Tablets as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $972K
- Providers
- 5
- Transactions
- 9
- Average per transaction
- $108,036
The per-transaction average — $108,036 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 5 providers the average total is $194,465, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| HRA Pharma | $972,325 | 100.0% |